# Hematologic Profile, Vit. B12 and Folic Acid in Cirrhotics Received Sofosbuvir and Daclatasvir With or Without Ribavirin

> **NCT03283176** · — · COMPLETED · sponsor: **Assiut University** · enrollment: 50 (actual)

## Conditions studied

- Liver Cirrhoses
- Chronic Hepatitis c
- Directly Acting Antivirals

## Interventions

- **DIAGNOSTIC_TEST:** Vitamin B12 and Folic Acid

## Key facts

- **NCT ID:** NCT03283176
- **Lead sponsor:** Assiut University
- **Sponsor class:** OTHER
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** COMPLETED
- **Start date:** 2018-03-01
- **Primary completion:** 2019-03-01
- **Final completion:** 2020-01-14
- **Target enrollment:** 50 (ACTUAL)
- **Last updated:** 2020-10-19


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT03283176

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT03283176, "Hematologic Profile, Vit. B12 and Folic Acid in Cirrhotics Received Sofosbuvir and Daclatasvir With or Without Ribavirin". Retrieved via AI Analytics 2026-05-22 from https://api.ai-analytics.org/clinical/NCT03283176. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*